Effects of a myocardial ischaemia-guided therapeutic program on survival and incidence of coronary events in asymptomatic patients with diabetes: the ARCADIA study

Diabetes and Metabolism

Volumn 33, Issue 6, 2007, Pages 459-465

  Vanzetto, G ^a   Boizel, R ^a   Halimi, S ^a   Ormezzano, O ^a   Belle, L ^a   Fagret, D ^a   Machecourt, J ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Coronary artery disease; Diabetes mellitus; Myocardial ischemia; Myocardial perfusion imaging; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DIURETIC THERAPY; DRUG EFFECT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INSULIN TREATMENT; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PERFUSION WEIGHTED IMAGING; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL; AGED; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; ELECTROCARDIOGRAPHY; FRANCE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; SURVIVOR;

AGED; AGED, 80 AND OVER; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ELECTROCARDIOGRAPHY; FEMALE; FRANCE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT SELECTION; RISK FACTORS; SURVIVORS;

EID: 36749033214     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.06.006     Document Type: Article

References (30)

1. Casiglia E., Zanette G., Mazza A., Donadon V., Donada C., Pizziol A., et al. Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. Eur. J. Epidemiol. 16 (2000) 677-684
2. Laing S.P., Swerdlow A.J., Slater S.D., Burden A.C., Morris A., Waugh N.R., et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46 (2003) 760-765
3. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 (1998) 229-234
4. Becker A., Bos G., de Vegt F., Kostense P.J., Dekker J.M., Nijpels G., et al. Cardiovascular events in type 2 diabetes: comparison with non diabetic individuals with and without prior cardiovascular disease. Eur. Heart J. 24 (2003) 1406-1413
5. Mak K.H., and Haffner S.M. Diabetes abolishes the gender gap in coronary heart disease. Eur. Heart J. 24 (2003) 1385-1386
6. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
7. Pollock S.G., Abbott R.D., Boucher C.A., Beller G.A., and Kaul S. Independent and incremental prognostic value of test performed in hierarchical order to evaluate patients with suspected coronary artery disease. Circulation 85 (1992) 237-248
8. Vanzetto G., Machecourt J., Blendea D., Fagret D., Borrel E., Magne J.L., et al. Additive value of Thallium-201 single photon computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am. J. Cardiol. 77 (1996) 143-148
9. Iskandrian A.S., Chae S.C., Heo J., Stanberry C.D., Wasserleben V., and Cave V. Independent and incremental prognostic value of exercise in single photon emission tomography (SPECT) Thallium imaging in coronary artery disease. J. Am. Coll. Cardiol. 22 (1993) 665-670
10. Pavin D., Delonca J., Siegenthaler M., Doat M., Rutishauser W., and Righetti A. Long term (10 years) prognostic value of a normal thallium - 201 myocardial exercise scintigraphy in patients with coronary artery disease documented by angiography. Eur. Heart J. 18 (1997) 69-77
11. Hachamovitch R., Berman D.S., Shaw L.J., Kiat H., Cohen I., Cabico J.A., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
12. Faglia E., Favales F., Calia P., Paleari F., Segalini G., Gamba P.L., et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease. 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 25 (2002) 2032-2036
13. Redberg R.F., Greenland P., Fuster V., Pyörälä K., Blair S.N., Folsom A.R., et al. AHA conference proceedings. Prevention conference VI. Diabetes and cardiovascular disease. Writing group III: Risk assessment in persons with diabetes. Circulation 105 (2002) e144-e152
14. Kamalesh M., Feigenbaum H., and Sawada S. Challenge of identifying patients with diabetes mellitus who are at low risk for coronary events by use of cardiac stress imaging. Am. Heart J. 147 (2004) 561-563
15. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
16. Vanzetto G., Halimi S., Hammoud T., Fagret D., Benhamou P.Y., Cordonnier D., et al. Prediction of cardiovascular events in clinically selected high risk NIDDM patients. Diabetes Care 22 (1999) 19-26
17. Taylor H.L., Jacobs D.R., Schucker B., Knudsen J., Leon A.S., and Debacker G. A questionnaire for the assessment of leisure time physical activities. J. Chronic Dis. 31 (1978) 741-755
18. Machecourt J., Longere P., Fagret D., Vanzetto G., Wolf J.E., Polidori C., et al. Prognostic Value of thallium -201 single photon emission computed tomography (thallium-SPECT) myocardial perfusion imaging according to the extent of myocardial defect. Study in 2013 patients with follow-up at 33 months. J. Am. Coll. Cardiol. 23 (1994) 1096-1106
19. Lee C.D., Folsom A.R., Pankow J.S., and Brancati F.L. for the Atherosclerosis Risk in Communities (ARIC) study investigators. Cardiovascular events in diabetic and non-diabetic adults with or without history of myocardial infarction. Circulation 109 (2004) 855-860
20. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial (MRFIT). Diabetes Care 16 (1993) 434-444
21. Sultan A., Piot C., Mariano-Goulart D., Daures J.P., Comte F., Renard E., et al. Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France. Diabet. Med. 23 (2006) 410-418
22. Kang X., Berman D.S., Lewin H.C., Cohen I., Friedman J.D., Germano G., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am. Heart J. 138 (1999) 1025-1032
23. De Lorenzo A., Lima R.S., Siqueira-Filho A.G., and Pantoja M.R. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am. J. Cardiol. 90 (2002) 827-832
24. Giri S., Shaw L.J., Murthy D.R., Travin M.I., Miller D.D., Hachamovitch R., et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105 (2002) 32-40
25. Mak K.H., and Faxon D.P. Clinical studies on coronary revascularization in patients with type 2 diabetes. Eur. Heart J. 24 (2003) 1087-1103
26. Mehran R., Dangas G.D., Kobayashi Y., Lansky A.J., Mintz G.S., Aymong E.D., et al. Short- and long-term results after multivessel stenting in diabetic patients. J. Am. Coll. Cardiol. 43 (2004) 1348-1354
27. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., and Berman D.S. Comparison of the short term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107 (2003) 2900-2906
28. Heart protection study collaborative group. MRC/BHF Heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet 361 (2003) 2005-2216
29. Heart outcome prevention evaluation (HOPE) study investigators. Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355 (2000) 253-259
30. Valensi P., Pariès J., Brulport-Cerisier V., Torremocha F., Sachs R.N., Vanzetto G., et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care 28 (2005) 2722-2727